深圳市瑞图生物技术有限公司，一家专注于人工智能与医学诊断深度融合的初创公司，日前宣布成功完成了超过1亿元人民币的B2轮融资。
本轮融资由中国科学院投资、国内知名基金领投，并得到了深圳投资控股资本的支持。同时，点石资本担任了此次融资的独家财务顾问。这标志着「瑞图生物」在人工智能与医学诊断领域的创新实践得到了业界的认可和支持。
「瑞图生物」成立于2017年，致力于通过人工智能技术推动医疗健康行业的发展。公司的核心团队来自于国内外顶级高校和科研机构，拥有深厚的技术积累和丰富的产业经验。
据悉，「瑞图生物」将继续加大研发投入，深化与医疗机构的合作，加速将科技成果转化为临床应用，为患者提供更精准、高效的医疗服务。同时，公司将借助本轮融资的资金，进一步扩大市场份额，提升品牌影响力。
此次融资的成功，不仅是「瑞图生物」发展的重要里程碑，也是中国人工智能与医学诊断领域的一次重要突破。未来，「瑞图生物」将以更加稳健的步伐，推动行业的创新发展，为人类健康事业作出更大的贡献。
英语如下：
News Title: “Ruìtú Biological Science and Technology Receives Over $10 Million B+ Round of Financing, Artificial Intelligence Boosts Medical Diagnosis!”
Keywords: Ruìtú Biological Science and Technology, B+ round of financing, artificial intelligence
News Content: The title: AI biomedical startup “Ruìtú Biological Science and Technology” successfully completed over 10 million RMB in B+ round of financing.
Shenzhen Ruìtú Biological Technology Co., Ltd., a startup focusing on the深度融合 of artificial intelligence and medical diagnosis, recently announced its successful completion of over 100 million yuan in B+ round of financing.
This round of financing was led by Chinese Academy of Sciences’ investment and supported by domestic well-known funds. Shenzhen Investment Holding Capital also provided support. Point Rock Capital served as the exclusive financial advisor for this round of financing. This marks that Ruìtú Biological Science and Technology’s innovative practices in the field of artificial intelligence and medical diagnosis have been recognized and supported by the industry.
Ruìtú Biological Science and Technology was founded in 2017 with the aim of promoting the development of the healthcare industry through artificial intelligence technology. The core team of the company comes from top universities and research institutions both domestically and internationally, with deep technical accumulations and rich industry experience.
It is reported that Ruìtú Biological Science and Technology will continue to increase its R&D input, deepen cooperation with medical institutions, accelerate the transformation of scientific and technological achievements into clinical applications, and provide more accurate and efficient medical services for patients. At the same time, the company will leverage the funding from this round of financing to further expand its market share and enhance brand influence.
The success of this round of financing is not only an important milestone in Ruìtú Biological Science and Technology’s development but also an important breakthrough in China’s artificial intelligence and medical diagnosis sector. In the future, Ruìtú Biological Science and Technology will take more steady steps, drive the innovation and development of the industry, and make greater contributions to human health cause.
【来源】https://www.vbdata.cn/1518942969
Views: 1